Ray Dalio's HUM Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 6,603 shares of Humana Inc. (HUM) worth $1.72 M, representing 0.01% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Ray Dalio has maintained a long-term strategic position in HUM, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2023, adding 85,640 shares. Largest reduction occurred in Q1 2024, reducing 90,772 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Humana (HUM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Humana (HUM) Trades by Ray Dalio
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +53,976 | Add 0.00% | 53,975 | $84.37 |
| Q3 2013 | -24,600 | Reduce 45.58% | 29,375 | $93.34 |
| Q4 2013 | -29,375 | Sold Out | 29,375 | $0.00 |
| Q3 2014 | +9,311 | New Buy | 9,311 | $130.28 |
| Q4 2014 | -300 | Reduce 3.22% | 9,011 | $143.60 |
| Q1 2015 | +3,500 | Add 38.84% | 12,511 | $178.00 |
| Q2 2015 | +11,100 | Add 88.72% | 23,611 | $191.27 |
| Q3 2015 | -23,611 | Sold Out | 23,611 | $0.00 |
| Q1 2020 | +7,267 | New Buy | 7,267 | $314.02 |
| Q2 2020 | -2,455 | Reduce 33.78% | 4,812 | $387.78 |
| Q3 2020 | -4,812 | Sold Out | 4,812 | $0.00 |
| Q3 2021 | +4,190 | New Buy | 4,190 | $389.26 |
| Q4 2021 | +22,797 | Add 544.08% | 26,987 | $463.85 |
| Q1 2022 | +8,324 | Add 30.84% | 35,311 | $435.16 |
| Q2 2022 | +18,399 | Add 52.11% | 53,710 | $468.07 |
| Q3 2022 | -11,991 | Reduce 22.33% | 41,719 | $485.20 |
| Q4 2022 | +7,641 | Add 18.32% | 49,360 | $512.19 |
| Q1 2023 | -37,016 | Reduce 74.99% | 12,344 | $485.46 |
| Q2 2023 | +11,054 | Add 89.55% | 23,398 | $447.13 |
| Q3 2023 | +15,440 | Add 65.99% | 38,838 | $486.52 |
| Q4 2023 | +85,640 | Add 220.51% | 124,478 | $457.81 |
| Q1 2024 | -90,772 | Reduce 72.92% | 33,706 | $346.72 |
| Q2 2024 | -32,405 | Reduce 96.14% | 1,301 | $373.65 |
| Q3 2024 | -327 | Reduce 25.13% | 974 | $316.74 |
| Q4 2024 | -974 | Sold Out | 974 | $0.00 |
| Q3 2025 | +6,603 | New Buy | 6,603 | $260.17 |
Ray Dalio's Humana Investment FAQs
Ray Dalio first purchased Humana Inc. (HUM) in Q2 2013, acquiring 53,975 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Humana Inc. (HUM) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's largest addition to Humana Inc. (HUM) was in Q4 2023, adding 124,478 shares worth $56.99 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 6,603 shares of Humana Inc. (HUM), valued at approximately $1.72 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Humana Inc. (HUM) represents approximately 0.01% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's peak holding in Humana Inc. (HUM) was 124,478 shares, as reported at the end of Q4 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.